Encore Well Labs Plus Fund, LP — Form D
Encore Well Labs Plus Fund, LP of Clayton, MO, a pooled investment fund, filed a Form D exempt-offering notice with the SEC on 2023-08-04. The offering totals $21.4M, of which $16.4M was reported sold. Industry: Other Health Care.
Offering
- Filed: 2023-08-04
- Form: D
- Accession: 0001988112-23-000001
- Industry: Other Health Care
- Exemptions: 06b, 3C, 3C.1, 3C.7
- Total offering: $21.4M
- Amount sold: $16.4M
- Remaining: $5.0M
- Investors: 12
- Date of first sale: 2023-07-31
- Security types: equity, fund interests
- Revenue range: Decline to Disclose
- SEC file number: 021-488837
Issuer
- Name: Encore Well Labs Plus Fund, LP
- CIK: 0001988112
- Entity type: Limited Partnership
- Jurisdiction: DELAWARE
- Incorporated: 2023
- Address: 8008 Carondelet Avenue, Clayton, MO, 63105
- Phone: 314-973-4557
Officers, directors & promoters (3)
| Name | Role | Location |
|---|
| N/A Encore Well Labs Plus GP, LLC | Director | Clayton, MO |
| Greg Siwak | Executive Officer | Clayton, MO |
| Todd Siwak | Executive Officer | Clayton, MO |
More